<DOC>
	<DOCNO>NCT02908386</DOCNO>
	<brief_summary>Given lack evidence benefit particle therapy relevant case , investigator propose silico trial investigate dosimetric effect contour change OAR well tumor chemoradiation H &amp; N patient . Photon proton-therapy compare base dosimetric data 7 time point treatment combine plan robustness . In way investigator able assess compare optimal timing replanning photon proton therapy . A database University Pennsylvania ( Upenn ) consist 10 patient head neck tumor treat chemo-radiation . Contrast-enhanced CT scan acquire prior RT ( T1-T7 )</brief_summary>
	<brief_title>ROCOCO - Adaptive IMRT Versus IMPT Head Neck Cancer</brief_title>
	<detailed_description>Given cost particle therapy ( PT ) considerably high conventional radiotherapy ( RT ) photon , necessary establish whether high cost worthwhile light expect advantage . Thus , clear evidence situation PT outperform conventional photon treatment need . ROCOCO ( Radiation Oncology COllaborative Comparison ) commence MAASTRO May 2007 evaluate PT 's cost-effectiveness . It well know radiation treatment head neck cancer ( HN ) , shrinkage displacement tumour organ risk ( OARs , e.g . parotid gland ) , well weight loss may cause significant radiation dose change target volume organ risk , , . These phenomenon may cause necessity re-plan treatment certain moment time . In last year many different treatment planning study perform show optimum moment re-planning varies : 20 Gy , 35 46 Gy . But actual effect deformation dose actually treat patient report . The investigator propose silico trial investigate relevance contour change OAR well tumor chemo radiation H &amp; N patient eventually lead replanning . In way investigator able assess compare optimal timing replanning photon proton therapy . The investigator compare different treatment focus effect deformation PTV coverage normal tissue radiation exposure . A fixed tumor dose , use delineation gross target volume ( GTV ) , clinical target volume ( CTV ) use . The planning target volume ( PTV ) determine treatment modality . For initial plan best possible dose distribution determine use planning-CT ( reference scan ) . For every time point ( CT-scan ) reference treatment plan project actual CT scan dose recalculate without change treatment parameter . This do use photon proton . All treatment uncertainty include robustness take account . Dose difference target volume ( CTV-GTV PTV ) OAR , result tumor shrinkage treatment evaluate time point treatment modality . The objective study ass plan robustness optimal timing replanning photon proton therapy .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>patient head neck carcinoma treat radical intent 10 patient , reference CT scan CT scan 7 time point treatment . patient head neck cancer</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Head neck tumor</keyword>
	<keyword>Proton</keyword>
	<keyword>Photon</keyword>
	<keyword>replanning timing</keyword>
</DOC>